Biologics
Sublingual Immunotherapy (SLIT) for indoor, outdoor, and food-related allergies
Targets the root cause of allergies by training your immune system over time
Convenient at-home treatment, shipped directly to you
Personalized formulas tailored to your specific allergy triggers
Clinician-guided care, prescribed and monitored by licensed Allergy Center providers
Starting at
$50/mo
Overview
Biologic medications are advanced therapies that target specific pathways in the immune system. They're used for severe allergic and asthmatic conditions that don't respond to standard treatments.
available
omalizumab
brand
Xolair
uses
- Moderate to severe allergic asthma
- Chronic spontaneous urticaria
mechanism
Blocks IgE antibodies
dupilumab
brand
Dupixent
uses
- Severe asthma with type 2 inflammation
- Atopic dermatitis
- Chronic rhinosinusitis with nasal polyps
mechanism
Blocks IL-4 and IL-13 pathways
mepolizumab
brand
Nucala
uses
- Severe eosinophilic asthma
mechanism
Targets IL-5
benralizumab
brand
Fasenra
uses
- Severe eosinophilic asthma
mechanism
Targets IL-5 receptor
when Considered
criteria
- Severe disease not controlled with standard therapies
- High medication burden with poor control
- Frequent exacerbations or hospitalizations
- Significant impact on quality of life
- Specific biomarkers or characteristics present (e.g., high IgE, eosinophilia)
evaluation
- Comprehensive assessment of disease severity
- Review of current medications and adherence
- Laboratory testing (IgE levels, eosinophil counts)
- Assessment of comorbidities
prior Authorization
process
- Detailed documentation of disease severity
- Evidence of inadequate control with standard therapies
- Laboratory results supporting indication
- Insurance company review and approval
- May require appeals process
documentation
- Medical records showing treatment history
- Spirometry results
- Exacerbation history
- Medication trials and responses
- Quality of life impact
timeline
Can take 1-4 weeks for approval
monitoring
initial
- Baseline laboratory studies
- Assessment of disease control
- Education on administration and side effects
ongoing
- Regular follow-up appointments (every 3-6 months)
- Assessment of response and side effects
- Laboratory monitoring as indicated
- Adjustment of other medications as needed
safety
- Monitor for injection site reactions
- Watch for signs of parasitic infections
- Assess for any new symptoms or concerns
outcomes
expected
- Reduced exacerbations
- Improved lung function (for asthma)
- Reduced need for oral corticosteroids
- Better quality of life
- Improved symptom control
timeline
- Some improvement may be seen within weeks
- Full benefit typically seen within 3-6 months
- Continued improvement over first year
response
Most patients see significant improvement, but response varies
Ready to Get Started?
Schedule a consultation to discuss your specific needs and create a personalized treatment plan.